Time and sequence dependence of hydroxyurea in combination with gemcitabine in human KB cells

Bingsen Zhou, Shu Mi, Xueli Mo, Jennifer Shih, Jeffery Tsai, Edward Hu, Margaret Hsu, Kristie Kay, Yun Yen

研究成果: 雜誌貢獻文章同行評審

23 引文 斯高帕斯(Scopus)

摘要

Gemcitabine (Gem) is a deoxycytidine analogue whose active metabolite, dFdCTP, blocks DNA elongation and has a cytotoxic effect. Hydroxyurea (HU) is an S-phase specific inhibitor of ribonucleotide reductase (RR) with a broad spectrum of antitumor effects. We report here that low-dose HU enhanced the activity of Gem in a time- and sequence-dependent manner. Exposure of human oropharyngeal carcinoma KB cells to HU followed by the addition of Gem at various times significantly enhanced cytotoxicity when compared to controls. The greatest enhancement of cytotoxicity occurred when Gem was added 8 hours after HU. By treating KB cells with radiolabeled-Gem following HU treatment, we further confirmed that the incorporation of dFdCTP into DNA increased 6-fold over control reactions under these conditions. The mechanism of the time- and sequence-dependent enhancement is associated with a decrease in hRRM2 RNA, protein, and activity between 4 and 8 hours. The subsequent depletion of dNTP pools allows for increased incorporation of dFdCTP into cells arrested in S-phase, resulting in higher levels of cytotoxicity than either treatment alone.

原文英語
頁(從 - 到)1369-1378
頁數10
期刊Anticancer Research
22
發行號3
出版狀態已發佈 - 八月 14 2002
對外發佈

ASJC Scopus subject areas

  • 癌症研究
  • 腫瘤科

指紋

深入研究「Time and sequence dependence of hydroxyurea in combination with gemcitabine in human KB cells」主題。共同形成了獨特的指紋。

引用此